fashion -WSS

fashion

author：hotspot 2025-09-27 13:05:05 - browse：658

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Wikipedia

focus

WSS

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Cheap, fast test for Zika and dengue could cost just $1

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Coercive sterilizations revealed by STAT prompt outrage

Why hospitals are withdrawing from US News rankings

Study: Why relieving medical debt did not improve financial outcomes

explore

fashion

explore

Cancer drug shortages should be causing more outrage

NIH tests clinical research in primary care with $30 million program

ChatGPT in medicine: STAT answers readers' burning questions

Study: Why relieving medical debt did not improve financial outcomes

Duchenne breakthrough therapy leaves behind pioneering families

Curing rare childhood diseases will falter unless Congress steps up

At least 13 dead in Texas as scorching temps continue

Medicare has a new plan to address drug shortages

Alkermes shareholders re

Report captures long Covid’s disabling effects and policy challenges

explore

Custom gene therapy hints at new path for rare disease treatments

Coercive sterilizations revealed by STAT prompt outrage

Why hospitals are withdrawing from US News rankings

Readers discuss the intersection of pregnancy and addiction

California wildfire smoke linked to 52,000 early deaths, study says

Custom gene therapy hints at new path for rare disease treatments

focus

Wikipedia

focus

focus